Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Attacking the roots of acute myeloid leukaemia (AML)
Professor Göttgens’ team is analysing thousands of genes in single cells to identify those that drive pre‑leukaemia and test whether disrupting them can prevent AML from developing.
Improving outcomes for people with MDS/MPN Overlap Syndromes
Discover Dr Daniel Wiseman's research into a new drug called ASTX727, to see if it can extend and improve the lives of people with MDS/MPN Overlap Syndromes.
Understanding how AML cancer cells deal with stress
Dr Papamichos and his team are researching how AML cancer cells deal with stress so they can find ways to stop these cancer cells dividing and multiplying out of control.
Targeting specific proteins in AML cancer cells
Dr Radzisheuskaya is seeking to understand the roles of specific proteins so she can develop more effective treatments for people with AML.
Understanding what causes blood cells to become cancerous
Read more about how Dr Payne and Dr Lubin plan to develop a new tool to help find new ways to prevent blood cancers from developing.
Understanding the role of mutations in the blood as we get older
Read more about Dr Kirschner's research which aims to identify mutations that occur in our blood cells so people at risk of developing blood cancer can be monitored.
Finding new ways to treat lymphoma
In this research project, Dr Hodson is looking for new ways to treat non-Hodgkin lymphoma.
Understanding what causes relapse in people with AML
In this project, Professor Bonnet wants to understand more about the cell that she thinks is responsible for AML returning.
Ensuring people with ALL get the most appropriate level of treatment
In this project, Professor Moorman is trying to find markers that can tell clinicians how much treatment someone with ALL needs.
Understanding how chemotherapy impacts quality of life in people with MDS
This research project will help us understand more about how quality of life changes throughout treatment which will allow clinicians to better support people with MDS in the future.
Understanding how CLL progresses
Dr Hoogeboom, King's College London wants to know more about how CLL cells move around the body and start growing.
Developing more effective and safer treatments for childhood leukaemia
This research explores why childhood ALL cells differ and how the disease begins, helping identify better, longer‑lasting treatments.
Finding new ways to treat aggressive chronic myeloid leukaemia (CML)
Professor David Vetrie and his team want to find ways to treat people whose Chronic myeloid leukaemia (CML) has stopped responding to treatment.
Reducing the risk of developing blood cancer in children with Shwachman-Diamond syndrome
Find out more about Professor Alan Warren's research to find new treatments for people with Schwachman-Diamond syndrome.
Reducing the need for chemotherapy in people with acute myeloid leukaemia (AML)
tba
Using the immune system to improve treatment for people with myeloma
Find out more about Dr Sarah Dimeloe's research into using our immune system to destroy cancerous Myeloma cells.
Improving treatment for people with lymphoma
tba
Understanding how CML turns into an aggressive disease
Discover Dr Gillian Horne's research into why chronic myeloid leukaemia (CML) can develop into an aggressive form of blood cancer.
Understanding changes in AML stem cells
Professor Bonifer and her team want to learn more about alterations in genes of AML cells to find new ways to treat it.
Developing a new type of treatment for leukaemia
Professor Rabbitts is developing a brand-new type of treatment which could provide a new option for people with leukaemia.
Understanding how leukaemia develops in children with Down’s syndrome
In this study, Professor Vyas will investigate how a genetic change present at birth in some children with Down’s syndrome can lead to leukaemia, and the steps involved.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.